Cargando…
A review of existing neonatal hyperbilirubinemia guidelines in Indonesia
BACKGROUND: Neonatal hyperbilirubinemia is one of the most common conditions for neonate inpatients. Indonesia faces a major challenge in which different guidelines regarding the management of this condition were present. This study aimed to compare the existing guidelines regarding prevention, diag...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682606/ https://www.ncbi.nlm.nih.gov/pubmed/38025296 http://dx.doi.org/10.12688/f1000research.110550.2 |
_version_ | 1785151012301963264 |
---|---|
author | Sampurna, Mahendra Tri Arif Pratama, Danny Chandra Visuddho, Visuddho Oktaviana, Novita Putra, Achmad Januar Er Zakiyah, Rahmi Ahmad, Jordy Maulana Etika, Risa Handayani, Kartika Darma Utomo, Martono Tri Angelica, Dina Ayuningtyas, Wurry Hendrarto, Toto Wisnu Rohsiswatmo, Rinawati Wandita, Setya Kaban, Risma Karina Liem, Kian Djien |
author_facet | Sampurna, Mahendra Tri Arif Pratama, Danny Chandra Visuddho, Visuddho Oktaviana, Novita Putra, Achmad Januar Er Zakiyah, Rahmi Ahmad, Jordy Maulana Etika, Risa Handayani, Kartika Darma Utomo, Martono Tri Angelica, Dina Ayuningtyas, Wurry Hendrarto, Toto Wisnu Rohsiswatmo, Rinawati Wandita, Setya Kaban, Risma Karina Liem, Kian Djien |
author_sort | Sampurna, Mahendra Tri Arif |
collection | PubMed |
description | BACKGROUND: Neonatal hyperbilirubinemia is one of the most common conditions for neonate inpatients. Indonesia faces a major challenge in which different guidelines regarding the management of this condition were present. This study aimed to compare the existing guidelines regarding prevention, diagnosis, treatment and monitoring in order to create the best recommendation for a new hyperbilirubinemia guideline in Indonesia. METHODS: Through an earlier survey regarding adherence to the neonatal hyperbilirubinemia guideline, we identified that three main guidelines are being used in Indonesia. These were developed by the Indonesian Pediatric Society (IPS), the Ministry of Health (MoH), and World Health Organization (WHO). In this study, we compared factors such as prevention, monitoring, methods for identifying, risk factors in the development of neonatal jaundice, risk factors that increase brain damage, and intervention treatment threshold in the existing guidelines to determine the best recommendations for a new guideline. RESULTS: The MoH and WHO guidelines allow screening and treatment of hyperbilirubinemia based on visual examination (VE) only. Compared with the MoH and WHO guidelines, risk assessment is comprehensively discussed in the IPS guideline. The MoH guideline recommends further examination of an icteric baby to ensure that the mother has enough milk without measuring the bilirubin level. The MoH guideline recommends referring the baby when it looks yellow on the soles and palms. The WHO and IPS guidelines recommend combining VE with an objective measurement of transcutaneous or serum bilirubin. The threshold to begin phototherapy in the WHO guideline is lower than the IPS guideline while the exchange transfusion threshold in both guidelines are comparably equal. CONCLUSIONS: The MoH guideline is outdated. MoH and IPS guidelines are causing differences in approaches to the management hyperbilirubinemia. A new, uniform guideline is required. |
format | Online Article Text |
id | pubmed-10682606 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-106826062023-11-30 A review of existing neonatal hyperbilirubinemia guidelines in Indonesia Sampurna, Mahendra Tri Arif Pratama, Danny Chandra Visuddho, Visuddho Oktaviana, Novita Putra, Achmad Januar Er Zakiyah, Rahmi Ahmad, Jordy Maulana Etika, Risa Handayani, Kartika Darma Utomo, Martono Tri Angelica, Dina Ayuningtyas, Wurry Hendrarto, Toto Wisnu Rohsiswatmo, Rinawati Wandita, Setya Kaban, Risma Karina Liem, Kian Djien F1000Res Research Article BACKGROUND: Neonatal hyperbilirubinemia is one of the most common conditions for neonate inpatients. Indonesia faces a major challenge in which different guidelines regarding the management of this condition were present. This study aimed to compare the existing guidelines regarding prevention, diagnosis, treatment and monitoring in order to create the best recommendation for a new hyperbilirubinemia guideline in Indonesia. METHODS: Through an earlier survey regarding adherence to the neonatal hyperbilirubinemia guideline, we identified that three main guidelines are being used in Indonesia. These were developed by the Indonesian Pediatric Society (IPS), the Ministry of Health (MoH), and World Health Organization (WHO). In this study, we compared factors such as prevention, monitoring, methods for identifying, risk factors in the development of neonatal jaundice, risk factors that increase brain damage, and intervention treatment threshold in the existing guidelines to determine the best recommendations for a new guideline. RESULTS: The MoH and WHO guidelines allow screening and treatment of hyperbilirubinemia based on visual examination (VE) only. Compared with the MoH and WHO guidelines, risk assessment is comprehensively discussed in the IPS guideline. The MoH guideline recommends further examination of an icteric baby to ensure that the mother has enough milk without measuring the bilirubin level. The MoH guideline recommends referring the baby when it looks yellow on the soles and palms. The WHO and IPS guidelines recommend combining VE with an objective measurement of transcutaneous or serum bilirubin. The threshold to begin phototherapy in the WHO guideline is lower than the IPS guideline while the exchange transfusion threshold in both guidelines are comparably equal. CONCLUSIONS: The MoH guideline is outdated. MoH and IPS guidelines are causing differences in approaches to the management hyperbilirubinemia. A new, uniform guideline is required. F1000 Research Limited 2023-11-13 /pmc/articles/PMC10682606/ /pubmed/38025296 http://dx.doi.org/10.12688/f1000research.110550.2 Text en Copyright: © 2023 Sampurna MTA et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Sampurna, Mahendra Tri Arif Pratama, Danny Chandra Visuddho, Visuddho Oktaviana, Novita Putra, Achmad Januar Er Zakiyah, Rahmi Ahmad, Jordy Maulana Etika, Risa Handayani, Kartika Darma Utomo, Martono Tri Angelica, Dina Ayuningtyas, Wurry Hendrarto, Toto Wisnu Rohsiswatmo, Rinawati Wandita, Setya Kaban, Risma Karina Liem, Kian Djien A review of existing neonatal hyperbilirubinemia guidelines in Indonesia |
title | A review of existing neonatal hyperbilirubinemia guidelines in Indonesia |
title_full | A review of existing neonatal hyperbilirubinemia guidelines in Indonesia |
title_fullStr | A review of existing neonatal hyperbilirubinemia guidelines in Indonesia |
title_full_unstemmed | A review of existing neonatal hyperbilirubinemia guidelines in Indonesia |
title_short | A review of existing neonatal hyperbilirubinemia guidelines in Indonesia |
title_sort | review of existing neonatal hyperbilirubinemia guidelines in indonesia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682606/ https://www.ncbi.nlm.nih.gov/pubmed/38025296 http://dx.doi.org/10.12688/f1000research.110550.2 |
work_keys_str_mv | AT sampurnamahendratriarif areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT pratamadannychandra areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT visuddhovisuddho areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT oktaviananovita areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT putraachmadjanuarer areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT zakiyahrahmi areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT ahmadjordymaulana areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT etikarisa areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT handayanikartikadarma areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT utomomartonotri areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT angelicadina areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT ayuningtyaswurry areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT hendrartototowisnu areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT rohsiswatmorinawati areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT wanditasetya areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT kabanrismakarina areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT liemkiandjien areviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT sampurnamahendratriarif reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT pratamadannychandra reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT visuddhovisuddho reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT oktaviananovita reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT putraachmadjanuarer reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT zakiyahrahmi reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT ahmadjordymaulana reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT etikarisa reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT handayanikartikadarma reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT utomomartonotri reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT angelicadina reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT ayuningtyaswurry reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT hendrartototowisnu reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT rohsiswatmorinawati reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT wanditasetya reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT kabanrismakarina reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia AT liemkiandjien reviewofexistingneonatalhyperbilirubinemiaguidelinesinindonesia |